clofibrate and aluminum

clofibrate has been researched along with aluminum in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19909 (90.00)18.7374
1990's1 (10.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Desager, JP; Harvengt, C1
Kronenwerth, D; Wallerstein, PV1
Buchmann, P; Göschke, H; Koller, F; Stähelin, HB; Strub, P; Thiel, G1
Hasegawa, R; Kurokawa, Y; Sai, K; Takagi, A; Umemura, T1
Locher, JT; Maier, R; Stähelin, HB1
Hayashi, E; Nagakura, T; Takeshita, R; Tomita, T1
Hartmann, G; Stähelin, HB1
Siegel, C1
Cloarec, M1
Fitzgerald, O; Heffernan, A; Hickey, N; Mulcahy, R1

Trials

1 trial(s) available for clofibrate and aluminum

ArticleYear
[Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1974, Jun-28, Volume: 99, Issue:26

    Topics: Adult; Aged; Aluminum; Cholesterol; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Drug Evaluation; Drug Tolerance; Female; Humans; Hyperlipidemias; Lipids; Lipoproteins; Male; Middle Aged; Phospholipids; Time Factors; Triglycerides

1974

Other Studies

9 other study(ies) available for clofibrate and aluminum

ArticleYear
Plasma clofibric acid (CPIB) levels induced by three marketed compounds releasing clofibric acid, in volunteers.
    International journal of clinical pharmacology and biopharmacy, 1977, Volume: 15, Issue:1

    Topics: Adult; Aluminum; Biological Availability; Clofibrate; Female; Humans; Kinetics; Male; Time Factors

1977
[Clinical experiences with vasoatherolip in early cerebral insufficiency].
    Fortschritte der Medizin, 1976, May-20, Volume: 94, Issue:15

    Topics: Aged; Aluminum; Brain Diseases; Clofibrate; Drug Evaluation; Female; Humans; Male; Middle Aged; Nicotinic Acids; Psychometrics

1976
[Studies on the heredity and pathogenesis of familial combined hyperlipidemia ("multiple lipoprotein type" hyperlipidemia)].
    Schweizerische medizinische Wochenschrift, 1976, Sep-25, Volume: 106, Issue:39

    Topics: Adolescent; Adult; Aged; Aluminum; Blood Group Antigens; Cholesterol; Clofibrate; Female; HLA Antigens; Humans; Hyperlipidemias; Male; Middle Aged; Pedigree; Phenotype; Triglycerides

1976
Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators; di(2-ethylhexyl) phthalate, aluminium clofibrate and simfibrate.
    Cancer letters, 1990, Volume: 53, Issue:1

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Aluminum; Animals; Catalase; Clofibrate; Death; Deoxyguanosine; Diethylhexyl Phthalate; DNA; DNA Damage; Hypolipidemic Agents; Kidney; Liver; Male; Microbodies; Oxidation-Reduction; Phthalic Acids; Rats; Time Factors

1990
Effect of Al-chlorophenoxyisobutyrate (Alufibrate) on pyruvate metabolism and on the fate of very low density lipoprotein lipids in hyperlipidemic patients.
    Clinica chimica acta; international journal of clinical chemistry, 1974, Jul-15, Volume: 54, Issue:1

    Topics: Adult; Aluminum; Butyrates; Carbon Dioxide; Carbon Radioisotopes; Cholesterol; Clofibrate; Electrophoresis; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Phenyl Ethers; Polysaccharides; Pyruvates; Respiration; Time Factors; Triglycerides

1974
Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
    Japanese journal of pharmacology, 1973, Volume: 23, Issue:3

    Topics: Aluminum; Animals; Anticholesteremic Agents; Body Weight; Butyrates; Cholesterol; Clofibrate; Fatty Acids, Nonesterified; Glucose Tolerance Test; Hypolipidemic Agents; Lipid Metabolism; Liver; Liver Glycogen; Male; Organ Size; Phenols; Phospholipids; Rats; Triglycerides

1973
[Antilipemic agents--long term therapy and tolerance].
    Die Medizinische Welt, 1973, Apr-06, Volume: 24, Issue:14

    Topics: Adult; Aged; Aluminum; Clofibrate; Drug Tolerance; Female; Humans; Hypolipidemic Agents; Lipids; Long-Term Care; Male; Middle Aged

1973
[Classification and treatment of hyperlipidemia: normolipemic treatments in 1972].
    Therapeutique (La Semaine des hopitaux), 1972, Volume: 48, Issue:10

    Topics: Aluminum; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Triglycerides; Xanthomatosis

1972
The chemotherapy of hypercholesterolaemia.
    Acta cardiologica, 1969, Volume: 24, Issue:1

    Topics: Aluminum; Androsterone; Anticholesteremic Agents; Clofibrate; Estrogens; Female; Humans; Hypercholesterolemia; Male; Nicotinic Acids; Propionates; Triparanol

1969